chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Per H&P:  Presenting for evaluation of laceration to the left medial forehead after the patient hit his head on an open car door.  Patient says he was under the car working and when he rolled out from under it the door was open and he went to sit up hitting the side of his head.  Patient states he hit his head so hard he initially saw stars however he denies loss of consciousness, headache, neck pain, nausea or vomiting. Per provider note: Patient's tetanus was updated today as it has been over 10 years since his last vaccination.  patient discharged home.   Per H&P:  Presenting via EMS for evaluation of possible allergic reaction.  Patient states he first felt dizzy and then nauseated and like his throat was closing.  He then experienced cough, chest pain and vomited twice.  EMS gave the patient 125 of Solu-Medrol, 50 of Benadryl, 0.5 epi IM and 2 of mag with improvement of his breathing and chest pains. He is now complaining of his entire body aching.  He denies any drug use prior to the incident.  Patient was seen in the emergency department today for a closed head injury and laceration repair with Dermabond and received a tetanus shot at that time.  Patient thinks that his reaction may be related to that as symptoms onset approximately 1 hour after discharge home. Had a tetanus shot in the past and tolerated it without complications.  Denies syncope, blurred vision, fever or abdominal pain.   In summary, patient is a 19 y.o. male presenting for evaluation by EMS for possible anaphylaxis after receiving tetanus shot in the emergency department earlier today.  Patient states that the resume the shot he had no symptoms and was discharged.  Approximately 1 hour after his discharge he began to experience dizziness, nausea, the sensation that his throat was closing.  Which also developed into cough, chest pain and 2 episodes of emesis.  Patient had pain all over and asked his mom to call 911.  EMS gave Solu-Medrol, Benadryl, epinephrine and mag with improvement of his breathing and chest pains in route.  Patient presents complaining of his entire body aching and some itching on the upper thighs.  Denies syncope, blurred vision, fever abdominal pain.     In the emergency department, the patient's vital signs are stable.  He is in mild distress secondary to diffuse myalgias.  Physical exam shows evidence of anaphylaxis with allergic shiners swelling of the eyelids.  Patient speaking in full sentences, no respiratory distress, lungs are clear to auscultation.  Remainder of exam is benign.  Given that patient was treated in route for anaphylaxis and his symptoms were resolving, plan is to monitor for 4 hours after epi dose for reemergence of his symptoms.  I gave patient 1 dose of Pepcid for itching.  EKG showed sinus bradycardia with no evidence of ischemic changes.  Lab studies were not obtained.  On signout, patient's vital signs are stable and he was resting comfortably.  If patient has no additional symptoms over the monitoring period, he may be discharged home with an EpiPen.  If his symptoms recur, he will be admitted for further monitoring and evaluation.  Patient signed out to Dr.
Patient called and complained her left arm was sore and tender for 3 days   Also stated she had a bump where the vaccine was administered and had a low grade fever for 2 days   Due to her arm being sore for 3 days she stated she is not sure she will get 2nd Shingrix Vaccine
patient received a lower amount of the vaccine; product is packaged without needles; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete dose administered in a patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2023-2024 season) (batch number 5ME77, expiry date 30-JUN-2024) for prophylaxis.   On an unknown date, the patient received Fluarix Tetra 2023-2024 season. On an unknown date, an unknown time after receiving Fluarix Tetra 2023-2024 season, the patient experienced incomplete dose administered (Verbatim: patient received a lower amount of the vaccine) and product packaging issue (Verbatim: product is packaged without needles).The outcome of the incomplete dose administered and product packaging issue were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 04-OCT-2023 The reporter called and reported that a pediatrician told them that whilst administering a dose of Fluarix, the needle suffered leakage and the patient received a lower amount of the vaccine, which led to incomplete dose administered. They gave partial information about the event and also gave the healthcare professional information. The reporter reported that the product was packaged without needles, which led to product packaging issue. The reporter consented to follow up.
3/20/23 I felt like a cold coming on and felt a little lethargic. By that evening, I had a sore throat, coughing, body wide pain and had trouble sleeping. I felt like I had the flu. I did an at home COVID test and it was positive. I called the doctor and was told to treat the symptoms. I started feeling better by the third day and by the fourth day, I felt pretty good. I had follow up problems about a week or two later. I was having problems with back pain, hip pain and sciatica nerve pain. My doctor felt like it was long term issues with Covid. I am having issues still with pain in the back of my right leg. I will begin taking Physical Therapy on 5/1/23.
Patient was admitted to medical facility on 7-12-21. She had fever, chills, nausea/vomiting, fatigue, shortness of breath, diarrhea, and light headed
Red lump on leg, hard and tender. Large local reaction with small bumps suggestive of vescules deep subdermal, trying to erupt. Definite reaction to shot.
I was providing IPV and Influenza vaccinations to forming recruits.  When giving one patient their 2nd vaccination, I noticed and hair and threw the vaccination in the sharps container.  I had assumed that I had thrown away the IPV vaccination, so I grabbed another IPV and provided it to the patient.  After the patient walked away, I looked in the sharps container and found a full influenza vaccination at the top of the pile.  This confirmed the patient received 2 IPV vaccinations in the left arm.  The patient then received his influenza vaccination.  The patient has not had any side effects or treatment from this.
Experienced unexplainable eye pain within a few days after receiving the vaccine and sought treatment from an eye doctor who prescribed me medicated eye drops to treat eye pain/potential infection. Pain in eyes then went away after treatment.
Patient had generalized itching with  no visible rash. Mild tachycardia (HR 106-113 bpm). Patient was observed for 30 minutes, during which time patient remained stable with no changes. Patient was released home
This spontaneous prospective was as received from a 36 year old female patient who was reporting on herself. The patient had no pertinent medical history, no drug reactions or allergies nor concomitant therapies. On an unknown date, the patient was vaccinated with the first dose of VARIVAX (Merck) (via subcutaneous route, lot # and expiration date were not reported). On an unknown date, the patient experienced injection site pain and swelling within 24 hours of VARIVAX (Merck) injection. On 08-DEC-2015, the patient was vaccinated with the second dose of VARIVAX (Merck) (via subcutaneous route, lot # and expiration date were not reported). In December 2015, the patient experienced injection site pain and swelling within 24 hours of VARIVAX (Merck) injection. On 28-DEC-2015, the patient discovered she was pregnant (the day when the pregnancy test was performed). The patient notified her physician and did not receive any treatment. The last menstrual period (LMP), estimate due date (EDD), estimated conception date (ECD) and trimester of exposure were unknown. The outcome of injection site pain and swelling was unknown. The relatedness between the events of injection site pain and swelling and VARIVAX (Merck) was not provided. Additional information is not expected as no contact details of HCP was provided.
I had no reaction to shot #1 other than a slightly sore arm.  After 36 hours and 12 minutes, I was awakened with a migraine, which I have now had for 10 days.  I tried treating with OTC, guafesin, and netti pot and it has only minimally improved my headache.  I visited the doctor today and he said there is inflammation in my sinuses and behind my ear drum.  He prescribed a 5 day-dose of Prednisone (reducing by 1 each day) to see if that will alleviate the inflammation and my headache.  Outsome unknonwn at this time.
Pt reports: "I received my flu and pneumonia shots on my left arm, it was excruciating that same day, and has been hurting ever since. Some days don't bother me much at all, but in general it is bothersome all the time. Some days it is just itchy, some days just hurts, sometimes so badly cannot sleep on that side. Says can still feel exactly where the injections were given". Denies redness or swelling at sites.
2/23/05 - c/o soreness, swollen and redness at injection site on left leg. Temp of 101-102 in pm  Was given Tylenol.  2/24/05 - no fever.  Left leg still red however, hard lump developed at injection site.  Friday 2/25/05, increase redness, pain continued in left leg, no fever.  2/26 & 2/27 - Injection site hard - size of a 50 cent piece.  Was sent home to use compress to left leg.  No signs of injection.
Initial report received on 07 October 2009 from a health care professional. A 47-year-old female patient, who had no concurrent illnesses or pre-existing medical conditions, had received an intramuscular right deltoid injection of FLUZONE SV 2009-2010 (lot number U3213AA) on 06 October 2009 at 11:00 am. It was reported that the patient had not experienced any adverse events with any vaccinations in the past; and she was not taking any concomitant medications at the time. Around 14:45 pm the same day, the patient returned to the office complaining of throat swelling, sore gums, watery eyes and painful thighs. At that point, the patient became unresponsive, cold, clammy and had decreased respirations. She was administered EPI and BENADRYL. The symptoms lasted 15 minutes. The patient was then sent to the emergency room via ambulance, and was administered PREDNISONE, ZANTAC and BENADRYL in the emergency room. After treatment, the patient was sent home directly from the emergency room. It was unknown if any relevant diagnostic tests or laboratory data were performed. At the time of this report, The patient was exhibiting some improvement. Per the reporter, the patient had not recovered. Documents held by sender: None.
A total of 40 out of 70 hemodialysis pts have not responded to a 3 dose regimen of either Engerix B or Heptavax; Heptavax used up until 1 yr ago & then started using Engerix-B; pts were only given 3 doses instead of recommended 4 doses;
Pt stated she started having rash and the c/o hives, stiff neck, sore muscles and itching. Pt stated she went to urgent care and was given prescription for ibuprofen, muscle relaxers and Benadryl.
A bump at the site of administration of the vaccine; A 3 inch rash at the site of administration of the vaccine; This spontaneous case from was received on 24-Sep-2020 from other non-health professional via The Agency (reference number: SEQW20-02263) and concerned a patient of an unknown age and gender.  The patient's medical history and concomitant medications were not reported.   On 17-Sep-2020, the patient was vaccinated with Flucelvax QIV (influenza vaccine, subunit influenza virus vaccine polyvalent, dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid) for influenza prophylaxis. The batch number reported was 283849, expiry date: 30-Jun-2021.   On the same day, after receiving Flucelvax QIV, the patient developed a bump and a 3-inch rash at the site of administration of the vaccine.  On an unspecified date in Sep-2020, the patient recovered from the events.  The reporter did not provide a causality assessment.   The case was assessed as non-serious.  This case is linked with cases: 202004697, 202004698, 202004699, 202004706, 202004701, 202004703, 202004704, 202004705, 202004678, 202004696 and 202004700.  Additional non-significant information received on 06-Jan-2021 from other non-health professional via The Agency (reference number: SEQW21-00065) and processed together with additional information received on 12-Jan-2021 from other health professional (reference number: SEQW21-00149): Two reporters were added. Reference numbers added. No changes in narrative.  Company comment: The patient developed vaccination site mass and vaccination site rash on the same day after vaccination with the suspect product, Flucelvax QIV. Chronology is suggestive. No information regarding concomitant medications and medical history was provided. Considering all information above, causal relationship for both events is assessed as possibly related. (defaults to ''related'' in the safety database for reporting purposes).; Sender's Comments: The patient developed vaccination site mass and vaccination site rash on the same day after vaccination with the suspect product, Flucelvax QIV. Chronology is suggestive. No information regarding concomitant medications and medical history was provided. Considering all information above, causal relationship for both events is assessed as possibly related. (defaults to ''related'' in the safety database for reporting purposes).
got the shot / they didn´t say anything about getting two shots; This case was reported by a consumer and described the occurrence of incomplete course of vaccination in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shigles vaccine (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not applicable for this report. The age group was not reported but it was captured as adult as per vaccine indication. The patient stated that he or she got the shot a little over a year later and they did not said anything about getting two shots. The patient hoped that it did not mean that he or she get them again. Till the time of reporting the patient had not received 2nd dose of Shingles vaccine which led to incomplete course of vaccination. This case had been linked with US2021AMR078749 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR078749:same IDM - SD - 2nd report
Pt experienced a mild case of chickenpox with 30 lesions on the torso and genital area, and one lesion on the scalp and on the lip.  5 -6 days later, the lesions were crusted over. The pt recovered.
Pt called c/o tingling on bilateral hand , foot and face after 20 minutes of receiving Pfizer vaccine. Pt advised to come back to the clinic  pt monitored for 45 minutes. Pt reports that she does not have tingling in her foot any more. Pt denies any SOB, any fast heart beat, swelling of face or throat, rash , dizziness or weakness. Spoke with the pt on 4/11/2021 10AM . Pt reports that she does not have any more tingling sensation.
Patient started feeling ill after his night shift started.  He worked as an overnight stocker at the location where he received the vaccination.  As the night went on, patient started feeling sick and after his lunch break around 2 am he got hot, feverish and was sweating profusely.  He went and sat down in the meat cooler to try and cool down for a few minutes.  After awhile he told his supervisor and a co-worker that he was leaving to go home sick.  He asked his co-worker to get the chair for him he left in the cooler and left his jacket there overnight.  It is not like patient to leave work early, much less ask someone to get a chair for him that he left behind.  The next night he called in sick again from work which was Sunday, Sept. 20, 2015.  He died later that evening according to paramedics whom did not find him until a good friend and next door neighbor found him laying on the floor in his home dead on Monday, Sept. 21 around 6:39 PM.  The paramedics and sheriff said he had been gone for possibly 18-24 hours.
Fever up to 105, body aches.  Tylenol helped.  Vaccine given on Saturday, pt feeling better by Monday.
on 17NOV92 low grade fever, on 19NOV92 pain under lt arm & across lt breasts-redness & swelling, very sl on 18OCT92;
Vaccinee was administered a 2nd Hepatitis B vaccination (? first dose Engerix-B); claimed "it pinched more the second time" as the inject was given;
Headache, nausea, diarrhea, lightheaded, dizzy, not eating much. Symptoms worsened next day and I went to emergency room was told I probably had food poisoning n exhausted from just having baby a week before. I was given 1 bag of fluid and released. I didn't realize it was from vaccine until I came home and went over my discharge papers and seen side effects of vaccine. When I returned to my obgyn I told her I believed it was vaccine n she told me it could have been but there's no exact way of knowing. The first day the symptoms were tolerable but the second day it was to the point where I thought I was going pass out so I went to ER. I just wish the ER dr asked if I received any shots or vaccines while I was in for the delivery and labor, I did return to the same hospital I gave birth in, the dr should've looked in my chart and realized it was side effect of vaccine. But I'm fine now but just want to report it, being that I just came home from hospital and had newborn, feeling that way was very scary.
Swollen lymph nodes in neck on left side same side as injection. Caused severe pain in the neck. Started about 54 hours after first dose and  Lasted about 48 hours.    Also experienced slight heart palpitations in the first 4 days following first dose.  Both side effects have subsided and I feel fine now.
Reported feeling dizzy, a dry throat and blurred vision. Alert and oriented x4, speaks in complete clear sentences. Denies SOB and pain. BP 182/90, P 89, O2 97%, R 19. No facial droop noted. No hearing deficit. Swallowing without difficulty. Lungs clear, heart sounds WNL.  Second set VS: BP 185/100, P 84, O2 96%, R 17. 15 minutes later patient reports symptoms improving. Recommended evaluation by physician. Patient refused EMS and plans to go to urgent care. Informed urgent care is not appropriate level of care and educated. Patient reports no symptoms upon discharge from clinic.
Approximately 15 hours after vaccine administration, patient experienced significant, severe, chest pain. Pain was a heavy, crushing pain without a reflux quality. Pain lasted for approximately 28 hours though decreased in severity after about 10 hours.   Uncomplicated, low-risk pregnancy of 30 weeks, 3 days at time of vaccine dose. EDD 11/17/2021. No known complications to pregnancy.
Pt recv vax on 3/3/99; within 15 min pt exp swollen/ red face, difficulty breathing, cough, wheezing, hives face & back; tx=Benadryl, Prednisone; dx=allergic rxn
This spontaneous prospective pregnancy report was received from a nurse and refers to a 25 year old female patient. On 06-OCT-2016, the patient was vaccinated with a dose of GARDASIL injection, 0,5 ml, intramuscularly, lot# M026306, expiration date 30-APR-2018 for prophylaxis. The patient became pregnant with last menstrual period (LMP) date of 05-OCT-2016 (calculated by sub tracking 11 weeks from 21-DEC-2016). On 11-NOV-2016, the patient got a positive result of an urine pregnancy test. On 21-DEC-2016, the patient was 11 weeks pregnant. Due date was estimated on 12-JUL-2017. No adverse event was reported. Additional information has been requested.
SHOULDER SWELLING; SHOULDER PAIN; SHOT WAS EXTREMELY PAINFUL; FLUSHED FEELING; DIFFICULTY LIFTING THE ARM; This spontaneous report received from a patient concerned an 84 year old female. The patient's weight was 100 pounds, and height was 157.48 centimeters. The patient's concurrent conditions included arthritis in left shoulder and mammals allergy. The patient had no illness at the time of vaccination. The patient had no past history of similar event. the patient had no adverse event after any previous vaccination(s). The patient had no pre-existing acute illness 30 days prior to vaccination. The patient had no history of hospitalization or acute illness in last 30 days, with cause. The patient had no family history of any disease (relevant to vaccination) or allergy. The patient had no other suspected causes including co-administered vaccine(s)/risk factors. The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 for left deltoid prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the patient experienced flushed feeling. On MAR-2021, the patientexperienced difficulty lifting the arm. On 15-MAR-2021, the patient experienced shot was extremely painful. On 19-MAR-2021, the patient experienced shoulder swelling. On 19-MAR-2021, the patient experienced shoulder pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shoulder pain, and shoulder swelling, and the outcome of flushed feeling, difficulty lifting the arm and shot was extremely painful was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
Fever 103.5 1 seizure on set 11/26/09 otitis media. Experiencing cough and cold symptoms for several days. Medication administered IBUPROFEN 10mg/kg po. AMOXICILLIN suspension 600mg po discharged home.
This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of herpes zoster (shingles) and dyspnea (breathing problem) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jan 15, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 5, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 15, 2021, after the mRNA-1273 (Moderna COVID-19 vaccine), patient experienced herpes zoster (shingles). On May 1, 2021, patient experienced dyspnea (breathing problem). At the time of the report, herpes zoster (shingles) and dyspnea (breathing problem) outcome: unknown. No concomitant medication or treatment information provided. Action taken with mRNA-1273 in response to the event: not applicable.
Patient was complaining of sinus cavities in nose getting tight and pain going into top of head. Also had dry mouth and dizzy.
The day after receiving the second dose, I had a temperature of 100-101 degrees, severe fatigue, moderate joint pain, headache, nausea, and soreness around injection site. The second day after receiving the second dose, I had a temperature of 99 degrees, a slight headache, and loss of appetite.
Child woke up @ 9PM 15APR91 w/highpitched cry which lasted for 30 min; could not be consoled; DTP leg red, swollen & warm to touch; No rxn in HIB leg;